Clinical trial
Assessment Of Safety And Efficacy Of SU11248 In Patients With Metastatic…
NCT00077987 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00077987 |
|---|---|
| Title | Assessment Of Safety And Efficacy Of SU11248 In Patients With Metastatic Colorectal Cancer Who Have Failed Selected Previous Treatments. |
| Official title | A Phase II Study Of SU011248 In Patients With Metastatic Colorectal Cancer Who Have Previously Failed Treatment With Irinotecan, Oxaliplatin, And A Fluoropyrimidine, With And Without Bevacizumab |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Neoplasms |
| Intervention type | Drug |
| Interventions | SU011248 |
| Enrollment | 84 |
| Start date | Dec 1, 2003 |
| Completion | Apr 1, 2005 |
| First posted | Feb 18, 2004 |
| Last update posted | Jan 11, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: